For instance, miR‐520c‐3p inhibits the invasion and migration of breast cancer by targeting IL‐8 and suppresses the invasion and migration of lung cancer by targeting AKT1 and AKT2 [30, 33]. Here, AKT2 is linked to lung carcinoma.